Canada Fingolimod 0.5 mg

1 INDICATIONS AND USAGE Fingolimod capsules are indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in patients 10 years of age and older. Fingolimod is a sphingosine 1-phosphate receptor modulator indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in patients 10 years of age and older. (1)

Sun Pharmaceutical Industries, Inc.

FDA Reported Adverse Reactions
`[1] fatigue` `[2] drug ineffective` `[3] off label use` `[4] nausea` `[5] pain` `[6] dyspnoea` `[7] headache` `[8] diarrhoea` `[9] arthralgia` `[10] pyrexia`

2 years ago

CAPSULE YELLOW yellow capsule 064 064

16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied 0.5 mg

FINGOLIMOD capsules are supplied as follows: Hard gelatin capsule, size '4' yellow cap and white body, axially imprinted with '064' on cap and on body in black ink, filled with white to off-white powder. Bottles of 30 with child resistant cap……………………………………...NDC 62756-064-83 Bottles of 90 with child resistant cap……………………………………...NDC 62756-064-81 Carton of 28 capsules containing 2 blister cards of 14 capsules per blister card NDC 62756-064-96 Carton of 7 capsules containing 1 blister card of 7 capsules per blister card NDC 62756-064-59 16.2 Storage and Handling

FINGOLIMOD capsules should be stored at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F) [see USP Controlled Room Temperature]. Protect from moisture.

More pills like CAPSULE yellow capsule 064 064

Comments

2 years ago - Thursday, Aug 25, 2022, 4:49 pm

Canada Fingolimod 0.5 mg [yellow capsule 064 064] https://www.jeancoutu.com/en/health/medication-dictionary/taro-fingolimod-capsule-05mg/02469618/

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site

Canada Fingolimod 0.5 mg

FDA Reported Adverse Reactions [1] fatigue [2] drug ineffective [3] off label use [4] nausea [5] pain [6] dyspnoea [7] headache [8] diarrhoea [9] arthralgia [10] pyrexia

CAPSULE YELLOW yellow capsule 064 064

More pills like CAPSULE yellow capsule 064 064

Comments

2 years ago - Thursday, Aug 25, 2022, 4:49 pm

FDA Reported Adverse Reactions
`[1] fatigue` `[2] drug ineffective` `[3] off label use` `[4] nausea` `[5] pain` `[6] dyspnoea` `[7] headache` `[8] diarrhoea` `[9] arthralgia` `[10] pyrexia`